Liposomal oncolytic adenovirus as a neoadjuvant therapy for triple-negative breast cancer

Abstract Breast cancer remains one of the leading causes of cancer-related death, with triple-negative breast cancer (TNBC) accounting for 15–20% of cases. TNBC, characterized by the absence of ER, PR, and HER2 protein, is an aggressive form of breast cancer that is unresponsive to hormonal therapie...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jaimin R. Shah, Tao Dong, Abraham T. Phung, Sohini Khan, Omonigho Aisagbonhi, Sarah L. Blair, Michael Bouvet, William C. Trogler, Andrew C. Kummel
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-05-01
coleção:	Scientific Reports
Assuntos:	Triple-negative breast cancer Neoadjuvant therapy Oncolytic adenovirus Coxsackievirus and adenovirus receptor Liposomes Metastasis
Acesso em linha:	https://doi.org/10.1038/s41598-025-00211-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!